Vitamin D Receptor Signaling and Cancer
- PMID: 29080633
- PMCID: PMC7092369
- DOI: 10.1016/j.ecl.2017.07.007
Vitamin D Receptor Signaling and Cancer
Abstract
The vitamin D receptor (VDR) binds the secosteroid hormone 1,25(OH)2D3 with high affinity and regulates gene programs that control a serum calcium levels, as well as cell proliferation and differentiation. A significant focus has been to exploit the VDR in cancer settings. Although preclinical studies have been strongly encouraging, to date clinical trials have delivered equivocal findings that have paused the clinical translation of these compounds. However, it is entirely possible that mining of genomic data will help to refine precisely what are the key anticancer actions of vitamin D compounds and where these can be used most effectively.
Keywords: Chemoprevention; Chemotherapy; Genomics; TCGA; Vitamin D.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
